UK markets close in 6 hours 42 minutes

Elevance Health, Inc. (0HG8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
535.17-0.32 (-0.06%)
As of 07:08PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 38.85%
S&P500 52-week change 324.19%
52-week high 3516.42
52-week low 30.00
50-day moving average 3493.40
200-day moving average 3466.52

Share statistics

Avg vol (3-month) 38.37k
Avg vol (10-day) 38.73k
Shares outstanding 5258.64M
Implied shares outstanding 6N/A
Float 8231.81M
% held by insiders 10.20%
% held by institutions 192.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 36.07
Trailing annual dividend yield 31.13%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.64%
Operating margin (ttm)7.52%

Management effectiveness

Return on assets (ttm)5.78%
Return on equity (ttm)15.95%

Income statement

Revenue (ttm)171.75B
Revenue per share (ttm)731.76
Quarterly revenue growth (yoy)1.00%
Gross profit (ttm)N/A
EBITDA 11.15B
Net income avi to common (ttm)6.24B
Diluted EPS (ttm)25.40
Quarterly earnings growth (yoy)12.90%

Balance sheet

Total cash (mrq)36.27B
Total cash per share (mrq)156.04
Total debt (mrq)26.45B
Total debt/equity (mrq)64.97%
Current ratio (mrq)1.38
Book value per share (mrq)174.62

Cash flow statement

Operating cash flow (ttm)3.57B
Levered free cash flow (ttm)-261.12M